首页> 外文期刊>European Journal of Radiology Open >Current update on combined hepatocellular-cholangiocarcinoma
【24h】

Current update on combined hepatocellular-cholangiocarcinoma

机译:合并肝细胞胆管癌的最新进展

获取原文
           

摘要

Combined hepatocellular-cholangiocarcinoma is a rare but unique primary hepatic tumor with characteristic histology and tumor biology. Recent development in genetics and molecular biology support the fact that combined hepatocellular-cholangiocarcinoma is closely linked with cholangiocarcinoma, rather than hepatocellular carcinoma. Combined hepatocellular cholangiocarcinoma tends to present with an more aggressive behavior and a poorer prognosis than either hepatocellular carcinoma or cholangiocarcinoma. An accurate preoperative diagnosis and aggressive treatment planning can play crucial roles in appropriate patient management.
机译:合并肝细胞胆管癌是一种罕见但独特的原发性肝癌,具有组织学和肿瘤生物学特征。遗传学和分子生物学的最新发展支持以下事实:合并的肝细胞胆管癌与胆管癌而不是肝细胞癌紧密相关。与肝细胞癌或胆管癌相比,合并的肝细胞胆管癌往往表现出更具侵略性的行为且预后较差。准确的术前诊断和积极的治疗计划可以在适当的患者管理中发挥关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号